Powered By Bing

Department of Biostatistics: Staff

Deqing Pei, MS

Publications:

  • Shen S, Chen X, Cai J, Yu J, Gao J, Hu S, Zhai X, Liang C, Ju X, Jiang H, Jin R, Wu X, Wang N, Tian X, Pan K, Jiang H, Sun L, Fang Y, Li CK, Hu Q, Yang M, Zhu Y, Zhang H, Li C, Pei D, Jeha S, Yang JJ, Cheng C, Tang J, Zhu X, Pui CH. Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncol :-, 2020. [Hematological Malignancies]. PMCID: PUBMEDID: 31944221 NIHMSID: . (Journal Impact Factor 2020=N/A)

  • Finch ER, Smith CA, Yang W, Liu Y, Kornegay NM, Panetta JC, Crews KR, Molinelli AR, Cheng C, Pei D, Ramsey LB, Karol SE, Inaba H, Sandlund JT, Metzger M, Evans WE, Jeha S, Pui CH, Relling MV. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 67:e28040-, 2020. [Hematological Malignancies]. PMCID: PMC6868303 PUBMEDID: 31612640 NIHMSID: . (Journal Impact Factor 2020=N/A)

  • Jeha S, Pei D, Choi J, Cheng C, Sandlund JT, Coustan-Smith E, Campana D, Inaba H, Rubnitz JE, Ribeiro RC, Gruber TA, Raimondi SC, Khan RB, Yang JJ, Mullighan CG, Downing JR, Evans WE, Relling MV, Pui CH. Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16. J Clin Oncol 37:3377-3391, 2019. [Hematological Malignancies]. PMCID: PUBMEDID: 31657981 NIHMSID: . (Journal Impact Factor 2019=28.245)

  • Janke LJ, Van Driest SL, Portera MV, Atreya RV, Denny JC, Pei D, Cheng C, Kaste SC, Inaba H, Jeha S, Pui CH, Relling MV, Karol SE. Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia. Blood 134:983-986, 2019. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC6753622 PUBMEDID: 31409674 NIHMSID: . (Journal Impact Factor 2019=16.562)

  • Liu Y, Smith CA, Panetta JC, Yang W, Thompson LE, Counts JP, Molinelli AR, Pei D, Kornegay NM, Crews KR, Swanson H, Cheng C, Karol SE, Evans WE, Inaba H, Pui CH, Jeha S, Relling MV. Antibodies predict pegaspargase allergic reactions and failure of rechallenge. J Clin Oncol 37:2051-2061, 2019. [Hematological Malignancies]. PMCID: PMC6804844 PUBMEDID: 31188727 NIHMSID: . (Journal Impact Factor 2019=28.245)

  • Finch ER, Janke LJ, Smith CA, Karol SE, Pei D, Cheng C, Kaste SC, Inaba H, Pui CH, Wolf J, Relling MV. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis. Pediatr Blood Cancer 66:e27669-, 2019. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC6472979 PUBMEDID: 30758124 NIHMSID: NIHMS1011642. (Journal Impact Factor 2019=2.486)

  • Pui CH, Pei D, Cheng C, Tomchuck SL, Evans SN, Inaba H, Jeha S, Raimondi SC, Choi JK, Thomas PG, Dallas MH. Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor. Oncoimmunology 8:1599637-, 2019. [Developmental Biology and Solid Tumor Program, Hematological Malignancies]. PMCID: PMC6682360 PUBMEDID: 31413907 NIHMSID: . (Journal Impact Factor 2019=5.333)

  • Hu Y, Chen A, Zheng X, Lu J, He H, Yang J, Zhang Y, Sui P, Yang J, He F, Wang Y, Xiao P, Liu X, Zhou Y, Pei D, Cheng C, Ribeiro RC, Hu S, Wang QF. Ecological principle meets cancer treatment: Treating children with acute myeloid leukemia with low-dose chemotherapy. Natl Sci Rev 6:469-479, 2019. [Hematological Malignancies]. PMCID: PUBMEDID: Not Indexed in PubMed NIHMSID: . (Journal Impact Factor 2019=13.222)

  • Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, Carmichael CL, Masih KE, Morris SM, Lindsley RC, Janke LJ, Alexander TB, Song G, Qu C, Li Y, Payne-Turner D, Tomizawa D, Kiyokawa N, Valentine M, Valentine V, Basso G, Locatelli F, Enemark EJ, Kham SKY, Yeoh AEJ, Ma X, Zhou X, Sioson E, Rusch M, Ries RE, Stieglitz E, Hunger SP, Wei AH, To LB, Lewis ID, D'Andrea RJ, Kile BT, Brown AL, Scott HS, Hahn CN, Marlton P, Pei D, Cheng C, Loh ML, Ebert BL, Meshinchi S, Haferlach T, Mullighan CG. Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nat Genet 51:694-704, 2019. [Cancer Biology, Hematological Malignancies]. PMCID: PMC6828160 PUBMEDID: 30926971 NIHMSID: . (Journal Impact Factor 2019=25.455)

  • Chellapandian D, Hines MR, Zhang R, Jeng M, van den Bos C, Santa-Maria Lopez V, Lehmberg K, Sieni E, Wang Y, Nakano T, Williams JA, Fustino NJ, Astigarraga I, Dunkel IJ, Abla O, van Halteren AGS, Pei D, Cheng C, Weitzman S, Sung L, Nichols KE. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis. Cancer 125:963-971, 2019. [Hematological Malignancies]. PMCID: PMC6786263 PUBMEDID: 30521100 NIHMSID: NIHMS996978. (Journal Impact Factor 2019=6.102)

  • Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC, Gastier-Foster J, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrozek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51:296-307, 2019. [Cancer Biology, Hematological Malignancies]. PMCID: PMC6525306 PUBMEDID: 30643249 NIHMSID: . (Journal Impact Factor 2019=25.455)

  • Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, Payne-Turner D, Yoshihara H, Loh ML, Horan J, Buldini B, Basso G, Elitzur S, de Haas V, Zwaan CM, Yeoh A, Reinhardt D, Tomizawa D, Kiyokawa N, Lammens T, De Moerloose B, Catchpoole D, Hori H, Moorman A, Moore AS, Hrusak O, Meshinchi S, Orgel E, Devidas M, Borowitz M, Wood B, Heerema NA, Carrol A, Yang YL, Smith MA, Davidsen TM, Hermida LC, Gesuwan P, Marra MA, Ma Y, Mungall AJ, Moore RA, Jones SJM, Valentine M, Janke LJ, Rubnitz JE, Pui CH, Ding L, Liu Y, Zhang J, Nichols KE, Downing JR, Cao X, Shi L, Pounds S, Newman S, Pei D, Guidry Auvil JM, Gerhard DS, Hunger SP, Inaba H, Mullighan CG. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature 562:373-379, 2018. [Cancer Biology, Hematological Malignancies]. PMCID: PMC6195459 PUBMEDID: 30209392 NIHMSID: NIHMS990315. (Journal Impact Factor 2018=43.07)

  • Cheung YT, Khan RB, Liu W, Brinkman TM, Edelmann MN, Reddick WE, Pei D, Panoskaltsis-Mortari A, Srivastava D, Cheng C, Robison LL, Hudson MM, Pui CH, Krull KR. Association of cerebrospinal fluid biomarkers of central nervous system injury with neurocognitive and brain imaging outcomes in children receiving chemotherapy for acute lymphoblastic leukemia. JAMA Oncol 4:e180089-, 2018. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC5885182 PUBMEDID: 29596541 NIHMSID: . (Journal Impact Factor 2018=22.416)

  • Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K. A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia. Cancer Manag Res 9:397-410, 2017. [Hematological Malignancies]. PMCID: PMC5602435 PUBMEDID: 28979163 NIHMSID: . (Journal Impact Factor 2017=3.702)

  • Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, Zhou X, Ma X, Sioson E, Li Y, Rusch M, Gupta P, Pei D, Cheng C, Smith MA, Auvil JG, Gerhard DS, Relling MV, Winick NJ, Carroll AJ, Heerema NA, Raetz E, Devidas M, Willman CL, Harvey RC, Carroll WL, Dunsmore KP, Winter SS, Wood BL, Sorrentino BP, Downing JR, Loh ML, Hunger SP, Zhang J, Mullighan CG. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet 49:1211-1218, 2017. [Cancer Biology, Hematological Malignancies]. PMCID: PMC5535770 PUBMEDID: 28671688 NIHMSID: NIHMS884462. (Journal Impact Factor 2017=27.125)

  • Liu C, Yang W, Pei D, Cheng C, Smith C, Landier W, Hageman L, Chen Y, Yang JJ, Crews KR, Kornegay N, Karol SE, Wong FL, Jeha S, Sandlund JT, Ribeiro RC, Rubnitz JE, Metzger ML, Pui CH, Evans WE, Bhatia S, Relling MV. Genomewide approach validates thiopurine methyltransferase activity is a monogenic pharmacogenomic trait. Clin Pharmacol Ther 101:373-381, 2017. [Hematological Malignancies]. PMCID: PMC5309133 PUBMEDID: 27564568 NIHMSID: NIHMS813676. (Journal Impact Factor 2017=6.544)

  • Stock W, Diouf B, Crews KR, Pei D, Cheng C, Laumann K, Mandrekar SJ, Luger S, Advani A, Stone RM, Larson RA, Evans WE. An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia. Clin Pharmacol Ther 101:391-395, 2017. [Hematological Malignancies]. PMCID: PMC5320866 PUBMEDID: 27618250 NIHMSID: NIHMS816918. (Journal Impact Factor 2017=6.544)

  • Pui CH, Pei D, Raimondi SC, Coustan-Smith E, Jeha S, Cheng C, Bowman WP, Sandlund JT, Ribeiro RC, Rubnitz JE, Inaba H, Gruber TA, Leung WH, Yang JJ, Downing JR, Evans WE, Relling MV, Campana D. Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy. Leukemia 31:333-339, 2017. [Hematological Malignancies]. PMCID: PMC5288281 PUBMEDID: 27560110 NIHMSID: NIHMS808623. (Journal Impact Factor 2017=10.023)

  • Roberts KG, Gu Z, Payne-Turner D, McCastlain K, Harvey RC, Chen IM, Pei D, Iacobucci I, Valentine M, Pounds SB, Shi L, Li Y, Zhang J, Cheng C, Rambaldi A, Tosi M, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Wiernik PH, Bhatia R, Aldoss I, Kohlschmidt J, Mrozek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, Mullighan CG. High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults. J Clin Oncol 35:394-401, 2017. [Cancer Biology, Hematological Malignancies]. PMCID: PMC5455698 PUBMEDID: 27870571 NIHMSID: . (Journal Impact Factor 2017=26.303)

  • Inaba H, Pei D, Wolf J, Howard SC, Hayden RT, Go M, Varechtchouk O, Hahn T, Buaboonnam J, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Evans WE, Relling MV, Pui CH. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol 28:386-392, 2017. [Hematological Malignancies]. PMCID: PMC5834143 PUBMEDID: 28426102 NIHMSID: . (Journal Impact Factor 2017=13.926)

  • Pasternak AL, Crews KR, Caudle KE, Smith C, Pei D, Cheng C, Broeckel U, Gaur AH, Hankins J, Relling MV, Haidar CE. The impact of the UGT1A1*60 allele on bilirubin serum concentrations. Pharmacogenomics 18:5-16, 2017. [Hematological Malignancies]. PMCID: PUBMEDID: 27967321 NIHMSID: . (Journal Impact Factor 2017=2.302)

  • Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, Wu G, Li Y, Wei L, Iacobucci I, Liu Y, Qu C, Wen J, Edmonson M, Payne-Turner D, Kaufmann KB, Takayanagi SI, Wienholds E, Waanders E, Ntziachristos P, Bakogianni S, Wang J, Aifantis I, Roberts KG, Ma J, Song G, Easton J, Mulder HL, Chen X, Newman S, Ma X, Rusch M, Gupta P, Boggs K, Vadodaria B, Dalton J, Liu Y, Valentine ML, Ding L, Lu C, Fulton RS, Fulton L, Tabib Y, Ochoa K, Devidas M, Pei D, Cheng C, Yang J, Evans WE, Relling MV, Pui CH, Jeha S, Harvey RC, Chen IL, Willman CL, Marcucci G, Bloomfield CD, Kohlschmidt J, Mrozek K, Paietta E, Tallman MS, Stock W, Foster MC, Racevskis J, Rowe JM, Luger S, Kornblau SM, Shurtleff SA, Raimondi SC, Mardis ER, Wilson RK, Dick JE, Hunger SP, Loh ML, Downing JR, Mullighan CG. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet 48:1481-1489, 2016. [Cancer Biology, Developmental Biology and Solid Tumor Program, Hematological Malignancies]. PMCID: PMC5144107 PUBMEDID: 27776115 NIHMSID: NIHMS832126. (Journal Impact Factor 2016=27.959)

  • Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, McCastlain K, Reshmi SC, Payne-Turner D, Iacobucci I, Shao Y, Chen IM, Valentine M, Pei D, Mungall KL, Mungall AJ, Ma Y, Moore R, Marra M, Stonerock E, Gastier-Foster JM, Devidas M, Dai Y, Wood B, Borowitz M, Larsen EE, Maloney K, Mattano LA Jr, Angiolillo A, Salzer WL, Burke MJ, Gianni F, Spinelli O, Radich JP, Minden MD, Moorman AV, Patel B, Fielding AK, Rowe JM, Luger SM, Bhatia R, Aldoss I, Forman SJ, Kohlschmidt J, Mrozek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, Loh ML, Hunger SP, Mullighan CG. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun 7:13331-, 2016. [Hematological Malignancies]. PMCID: PMC5105166 PUBMEDID: 27824051 NIHMSID: . (Journal Impact Factor 2016=12.124)

  • Elbahlawan LM, Avent Y, Montoya L, Wilder K, Pei D, Cheng C, Morrison RR, Jeha S. Safety and benefits of bronchoalveolar lavage and lung biopsy in the management of pulmonary infiltrates in children with leukemia. J Pediatr Hematol Oncol 38:597-601, 2016. [Hematological Malignancies]. PMCID: PMC5699503 PUBMEDID: 27467366 NIHMSID: . (Journal Impact Factor 2016=1.076)

  • Jacola LM, Krull KR, Pui CH, Pei D, Cheng C, Reddick WE, Conklin HM. Reply to S. Kaur et al. J Clin Oncol 34:3708-3709, 2016. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PUBMEDID: 27551120 NIHMSID: . (Journal Impact Factor 2016=24.008)

  • Watts CS, Sciasci JN, Pauley JL, Panetta JC, Pei D, Cheng C, Christensen CM, Mikkelsen TS, Pui CH, Jeha S, Relling MV. Prophylactic trimethoprim-sulfamethoxazole does not affect pharmacokinetics or pharmacodynamics of methotrexate. J Pediatr Hematol Oncol 38:449-452, 2016. [Hematological Malignancies]. PMCID: PMC4955728 PUBMEDID: 27322715 NIHMSID: NIHMS787755. (Journal Impact Factor 2016=1.076)

  • Diouf B, Devaraju P, Janke LJ, Fan Y, Frase S, Eddins D, Peters JL, Kim J, Pei D, Cheng C, Zakharenko SS, Evans WE. Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion, and altered sensory function in mice. Sci Rep 6:30757-, 2016. [Hematological Malignancies, Neurobiology & Brain Tumor]. PMCID: PMC4967871 PUBMEDID: 27476972 NIHMSID: . (Journal Impact Factor 2016=4.259)

  • Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, Estepp JH, Pei D, Broeckel U, Wang W, Weiss MJ, Relling MV, Hankins J. Pharmacogenetics for safe codeine use in sickle cell eisease. Pediatrics 138:-, 2016. [Hematological Malignancies]. PMCID: PMC4925073 PUBMEDID: 27335380 NIHMSID: . (Journal Impact Factor 2016=5.705)

  • Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C, Carroll WL, Raetz EA, Bowman WP, Larsen EC, Maloney KW, Martin PL, Mattano LA Jr, Winick NJ, Mardis ER, Fulton RS, Bhojwani D, Howard SC, Jeha S, Pui CH, Hunger SP, Evans WE, Loh ML, Relling MV. Clinical and genetic risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia. J Clin Oncol 34:2133-2140, 2016. [Hematological Malignancies]. PMCID: PMC4962704 PUBMEDID: 27114598 NIHMSID: . (Journal Impact Factor 2016=24.008)

  • Zhao Y, Nguyen P, Ma J, Wu T, Jones LL, Pei D, Cheng C, Geiger TL. Preferential use of public TCR during autoimmune encephalomyelitis. J Immunol 196:4905-4914, 2016. [Hematological Malignancies]. PMCID: PMC4902001 PUBMEDID: 27183575 NIHMSID: NIHMS779404. (Journal Impact Factor 2016=4.856)

  • Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, Jiang L, Li JF, Wang MJ, Dai YJ, Zhang ZG, Wang Q, Kong J, Chen B, Zhu YM, Weng XQ, Shen ZX, Li JM, Wang J, Yan XJ, Li Y, Liang YM, Liu L, Chen XQ, Zhang WG, Yan JS, Hu JD, Shen SH, Chen J, Gu LJ, Pei D, Li Y, Wu G, Zhou X, Ren RB, Cheng C, Yang JJ, Wang KK, Wang SY, Zhang J, Mi JQ, Pui CH, Tang JY, Chen Z, Chen SJ. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine 8:173-183, 2016. [Cancer Biology, Hematological Malignancies]. PMCID: PMC4919728 PUBMEDID: 27428428 NIHMSID: . (Journal Impact Factor 2016=N/A)

  • Anghelescu DL, Patel RM, Mahoney DP, Trujillo L, Faughnan LG, Steen BD, Baker JN, Pei D. Methadone prolongs cardiac conduction in young patients with cancer-related pain. J Opioid Manag 12:131-138, 2016. [Hematological Malignancies]. PMCID: PMC5073866 PUBMEDID: 27194198 NIHMSID: NIHMS812443. (Journal Impact Factor)

  • Jacola LM, Krull KR, Pui CH, Pei D, Cheng C, Reddick WE, Conklin HM. Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol. J Clin Oncol 34:1239-1247, 2016. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC4872325 PUBMEDID: 26858334 NIHMSID: . (Journal Impact Factor 2016=24.008)

  • Hakim H, Dallas R, Zhou Y, Pei D, Cheng C, Flynn PM, Pui CH, Jeha S. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia. Cancer 122:798-805, 2016. [Hematological Malignancies]. PMCID: PMC4764417 PUBMEDID: 26700662 NIHMSID: NIHMS741212. (Journal Impact Factor 2016=5.997)

  • Mullighan CG, Jeha S, Pei D, Payne-Turner D, Coustan-Smith E, Roberts KG, Waanders E, Choi JK, Ma X, Raimondi SC, Fan Y, Yang W, Song G, Yang JJ, Inaba H, Downing JR, Leung WH, Bowman WP, Relling MV, Evans WE, Zhang J, Campana D, Pui CH. Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels. Blood 126:2896-2899, 2015. [Cancer Biology, Hematological Malignancies]. PMCID: PMC4692147 PUBMEDID: 26527677 NIHMSID: . (Journal Impact Factor 2015=11.841)

  • Karol SE, Yang W, Van Driest SL, Chang TY, Kaste S, Bowton E, Basford M, Bastarache L, Roden DM, Denny JC, Larsen E, Winick N, Carroll WL, Cheng C, Pei D, Fernandez CA, Liu C, Smith C, Loh ML, Raetz EA, Hunger SP, Scheet P, Jeha S, Pui CH, Evans WE, Devidas M, Mattano LA Jr, Relling MV. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood 126:1770-1776, 2015. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC4600016 PUBMEDID: 26265699 NIHMSID: . (Journal Impact Factor 2015=11.841)

  • Anghelescu DL, Zhang K, Faughnan LG, Pei D. The safety and effectiveness of patient-controlled analgesia in outpatient children and young adults with cancer: A retrospective study. J Pediatr Hematol Oncol 37:378-382, 2015. [Hematological Malignancies]. PMCID: PMC4683407 PUBMEDID: 26018808 NIHMSID: NIHMS740579. (Journal Impact Factor 2015=1.146)

  • Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C, Pei D, Chen Y, Crews KR, Kornegay N, Wong FL, Evans WE, Pui CH, Bhatia S, Relling MV. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 33:1235-1242, 2015. [Hematological Malignancies]. PMCID: PMC4375304 PUBMEDID: 25624441 NIHMSID: . (Journal Impact Factor 2015=20.982)

  • Andersson AK, Ma J, Wang J, Chen X, Gedman AL, Dang J, Nakitandwe J, Holmfeldt L, Parker M, Easton J, Huether R, Kriwacki R, Rusch M, Wu G, Li Y, Mulder H, Raimondi S, Pounds S, Kang G, Shi L, Becksfort J, Gupta P, Payne-Turner D, Vadodaria B, Boggs K, Yergeau D, Manne J, Song G, Edmonson M, Nagahawatte P, Wei L, Cheng C, Pei D, Sutton R, Venn NC, Chetcuti A, Rush A, Catchpoole D, Heldrup J, Fioretos T, Lu C, Ding L, Pui CH, Shurtleff S, Mullighan CG, Mardis ER, Wilson RK, Gruber TA, Zhang J, Downing JR. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet 47:330-337, 2015. [Cancer Biology, Hematological Malignancies]. PMCID: PMC4553269 PUBMEDID: 25730765 NIHMSID: NIHMS661223. (Journal Impact Factor 2015=31.616)

  • Pui CH, Pei D, Coustan-Smith E, Jeha S, Cheng C, Bowman WP, Sandlund JT, Ribeiro RC, Rubnitz JE, Inaba H, Bhojwani D, Gruber TA, Leung WH, Downing JR, Evans WE, Relling MV, Campana D. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol 16:465-474, 2015. [Hematological Malignancies]. PMCID: PMC4612585 PUBMEDID: 25800893 NIHMSID: NIHMS729876. (Journal Impact Factor 2015=26.509)

  • Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WE. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 313:815-823, 2015. [Cancer Biology, Hematological Malignancies]. PMCID: PMC4377066 PUBMEDID: 25710658 NIHMSID: NIHMS667277. (Journal Impact Factor 2015=37.684)

  • Kaste SC, Pei D, Cheng C, Neel MD, Bowman WP, Ribeiro RC, Metzger ML, Bhojwani D, Inaba H, Campbell P, Rubnitz JE, Jeha S, Sandlund JT, Downing JR, Relling MV, Pui CH, Howard SC. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol 33:610-615, 2015. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC4322260 PUBMEDID: 25605853 NIHMSID: . (Journal Impact Factor 2015=20.982)

  • Pui CH, Pei D, Campana D, Cheng C, Sandlund JT, Bowman WP, Hudson MM, Ribeiro RC, Raimondi SC, Jeha S, Howard SC, Bhojwani D, Inaba H, Rubnitz JE, Metzger ML, Gruber TA, Coustan-Smith E, Downing JR, Leung WH, Relling MV, Evans WE. A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia 28:2336-2343, 2014. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC4214904 PUBMEDID: 24781017 NIHMSID: NIHMS585627. (Journal Impact Factor 2014=10.431)

  • Bhojwani D, Darbandi R, Pei D, Ramsey LB, Chemaitilly W, Sandlund JT, Cheng C, Pui CH, Relling MV, Jeha S, Metzger ML. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer 50:2685-2694, 2014. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC4180109 PUBMEDID: 25087182 NIHMSID: NIHMS614957. (Journal Impact Factor 2014=5.417)

  • Roberts KG, Pei D, Campana D, Payne-Turner D, Li Y, Cheng C, Sandlund JT, Jeha S, Easton J, Becksfort J, Zhang J, Coustan-Smith E, Raimondi SC, Leung WH, Relling MV, Evans WE, Downing JR, Mullighan CG, Pui CH. Outcomes of Children With BCR-ABL1-Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease. J Clin Oncol 32:3012-3020, 2014. [Hematological Malignancies]. PMCID: PMC4162497 PUBMEDID: 25049327 NIHMSID: . (Journal Impact Factor 2014=18.443)

  • Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen SC, Easton J, Cheng J, Boggs K, Santiago-Morales N, Iacobucci I, Fulton RS, Wen J, Valentine M, Cheng C, Paugh SW, Devidas M, Chen IM, Reshmi S, Smith A, Hedlund E, Gupta P, Nagahawatte P, Wu G, Chen X, Yergeau D, Vadodaria B, Mulder H, Winick NJ, Larsen EC, Carroll WL, Heerema NA, Carroll AJ, Grayson G, Tasian SK, Moore AS, Keller F, Frei-Jones M, Whitlock JA, Raetz EA, White DL, Hughes TP, Guidry Auvil JM, Smith MA, Marcucci G, Bloomfield CD, Mrozek K, Kohlschmidt J, Stock W, Kornblau SM, Konopleva M, Paietta E, Pui CH, Jeha S, Relling MV, Evans WE, Gerhard DS, Gastier-Foster JM, Mardis E, Wilson RK, Loh ML, Downing JR, Hunger SP, Willman CL, Zhang J, Mullighan CG. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371:1005-1015, 2014. [Cancer Biology, Hematological Malignancies]. PMCID: PMC4191900 PUBMEDID: 25207766 NIHMSID: NIHMS632485. (Journal Impact Factor 2014=55.873)

  • Hicks JK, Crews KR, Flynn P, Haidar CE, Daniels CC, Yang W, Panetta JC, Pei D, Scott JR, Molinelli AR, Broeckel U, Bhojwani D, Evans WE, Relling MV. Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics 15:1065-1078, 2014. [Hematological Malignancies]. PMCID: PMC4155516 PUBMEDID: 25084200 NIHMSID: NIHMS620654. (Journal Impact Factor 2014=3.218)

  • Jeha S, Coustan-Smith E, Pei D, Sandlund JT, Rubnitz JE, Howard SC, Inaba H, Bhojwani D, Metzger ML, Cheng C, Choi JK, Jacobsen J, Shurtleff SA, Raimondi S, Ribeiro RC, Pui CH, Campana D. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 120:1514-1519, 2014. [Hematological Malignancies]. PMCID: PMC4249731 PUBMEDID: 24501014 NIHMSID: NIHMS562051. (Journal Impact Factor 2014=5.068)

  • Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32:949-959, 2014. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC3948096 PUBMEDID: 24550419 NIHMSID: . (Journal Impact Factor 2014=18.443)

  • Anghelescu DL, Faughnan LG, Popenhagen MP, Oakes LL, Pei D, Burgoyne LL. Neuropathic pain referrals to a multidisciplinary pediatric cancer pain service. Pain Manag Nurs 15:126-131, 2014. [Hematological Malignancies]. PMCID: PMC3950814 PUBMEDID: 24602431 NIHMSID: NIHMS396331. (Journal Impact Factor 2014=1.529)

  • Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, E S, Lim JY, Chen IM, Fan Y, Devidas M, Borowitz MJ, Smith C, Neale G, Burchard EG, Torgerson DG, Klussmann FA, Villagran CR, Winick NJ, Camitta BM, Raetz E, Wood B, Yue F, Carroll WL, Larsen E, Bowman WP, Loh ML, Dean M, Bhojwani D, Pui CH, Evans WE, Relling MV, Hunger SP, Willman CL, Mullighan CG, Yang JJ. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 45:1494-1498, 2013. [Hematological Malignancies]. PMCID: PMC4039076 PUBMEDID: 24141364 NIHMSID: NIHMS568109. (Journal Impact Factor 2013=29.648)

  • Pauley JL, Panetta JC, Crews KR, Pei D, Cheng C, McCormick J, Howard SC, Sandlund JT, Jeha S, Ribeiro R, Rubnitz J, Pui CH, Evans WE, Relling MV. Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. Cancer Chemother Pharmacol 72:1375-, 2013. [Hematological Malignancies]. PMCID: PUBMEDID: 24166105 NIHMSID: . (Journal Impact Factor 2013=2.571)

  • Pauley JL, Panetta JC, Crews KR, Pei D, Cheng C, McCormick J, Howard SC, Sandlund JT, Jeha S, Ribeiro R, Rubnitz J, Pui CH, Evans WE, Relling MV. Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. Cancer Chemother Pharmacol 72:369-378, 2013. [Hematological Malignancies]. PMCID: PMC3719000 PUBMEDID: 23760811 NIHMSID: . (Journal Impact Factor 2013=2.571)

  • Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, Sandlund JT, Pui CH. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2182-2188, 2013. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC3731978 PUBMEDID: 23650422 NIHMSID: . (Journal Impact Factor 2013=17.96)

  • Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, Camitta BM, Bowman WP, Willman CL, Carroll WL, Mullighan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML, Yang JJ. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 105:733-742, 2013. [Hematological Malignancies]. PMCID: PMC3691938 PUBMEDID: 23512250 NIHMSID: . (Journal Impact Factor 2013=15.161)

  • Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, McCastlain K, Becksfort J, Ma J, Wu G, Patel SN, Heatley SL, Phillips LA, Song G, Easton J, Parker M, Chen X, Rusch M, Boggs K, Vadodaria B, Hedlund E, Drenberg C, Baker S, Pei D, Cheng C, Huether R, Lu C, Fulton RS, Fulton LL, Tabib Y, Dooling DJ, Ochoa K, Minden M, Lewis ID, To LB, Marlton P, Roberts AW, Raca G, Stock W, Neale G, Drexler HG, Dickins RA, Ellison DW, Shurtleff SA, Pui CH, Ribeiro RC, Devidas M, Carroll AJ, Heerema NA, Wood B, Borowitz MJ, Gastier-Foster JM, Raimondi SC, Mardis ER, Wilson RK, Downing JR, Hunger SP, Loh ML, Mullighan CG. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 45:242-252, 2013. [Cancer Biology, Hematological Malignancies, Neurobiology & Brain Tumor]. PMCID: PMC3919793 PUBMEDID: 23334668 NIHMSID: NIHMS491209. (Journal Impact Factor 2013=29.648)

  • Liu C, Kawedia JD, Cheng C, Pei D, Fernandez CA, Cai X, Crews KR, Kaste SC, Panetta JC, Bowman WP, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia 26:2303-2309, 2012. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3516853 PUBMEDID: 22484422 NIHMSID: NIHMSID418827. (Journal Impact Factor 2012=10.164)

  • Stocco G, Yang W, Crews KR, Thierfelder WE, Decorti G, Londero M, Franca R, Rabusin M, Valsecchi MG, Pei D, Cheng C, Paugh SW, Ramsey LB, Diouf B, McCorkle JR, Jones TS, Pui CH, Relling MV, Evans WE. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 21:4793-4804, 2012. [Hematological Malignancies]. PMCID: PMC3471396 PUBMEDID: 22846425 NIHMSID: . (Journal Impact Factor 2012=7.692)

  • Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst 104:1386-1395, 2012. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC3529594 PUBMEDID: 22927505 NIHMSID: . (Journal Impact Factor 2012=14.336)

  • Sharma S, Leung WH, Deqing P, Yang J, Rochester R, Britton L, Neel MD, Ness KK, Kaste SC. Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant 47:1067-1074 , 2012. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3310343 PUBMEDID: 22158389 NIHMSID: NIHMS328223. (Journal Impact Factor 2012=3.541)

  • Anghelescu DL, Faughnan LG, Oakes LL, Windsor KB, Pei D, Burgoyne LL. Parent-controlled PCA for pain management in pediatric oncology: is it safe? J Pediatr Hematol Oncol 34:416-420, 2012. [Hematological Malignancies]. PMCID: PMC3400718 PUBMEDID: 22767126 NIHMSID: NIHMS374161. (Journal Impact Factor 2012=0.973)

  • Leung W, Pui CH, Coustan-Smith E, Yang J, Pei D, Gan K, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Shook D, Rubnitz JE, Sandlund JT, Jeha S, Inaba H, Ribeiro RC, Handgretinger R, Laver JH, Campana D. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood 120:468-472, 2012. [Developmental Biology and Solid Tumor Program, Signal Transduction, Hematological Malignancies]. PMCID: PMC3398757 PUBMEDID: 22517895 NIHMSID: . (Journal Impact Factor 2012=9.06)

  • Pui CH, Pei D, Pappo AS, Howard SC, Cheng C, Sandlund JT, Furman WL, Ribeiro RC, Spunt SL, Rubnitz JE, Jeha S, Hudson MM, Kun LE, Merchant TE, Kocak M, Broniscer A, Metzger ML, Downing JR, Leung W, Evans WE, Gajjar A. Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol 30:2005-2012, 2012. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC3383176 PUBMEDID: 22547602 NIHMSID: . (Journal Impact Factor 2012=18.038)

  • Elbahlawan L, McArthur J, Quasney MW, Pei D, Srivastava K, Dahmer MK, Barfield R. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 34:175-179, 2012. [Hematological Malignancies]. PMCID: PUBMEDID: 22395218 NIHMSID: . (Journal Impact Factor 2012=0.973)

  • Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, Evans WE, Pui CH, Hunger SP, Relling MV, Yang JJ. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30:751-757, 2012. [Hematological Malignancies]. PMCID: PMC3295551 PUBMEDID: 22291082 NIHMSID: . (Journal Impact Factor 2012=18.038)

  • Kawedia JD, Liu C, Pei D, Cheng C, Fernandez CA, Howard SC, Campana D, Panetta JC, Bowman WP, Evans WE, Pui CH, Relling MV. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood 119:1658-1664, 2012. [Hematological Malignancies]. PMCID: PMC3286344 PUBMEDID: 22117041 NIHMSID: . (Journal Impact Factor 2012=9.06)

  • Bhojwani D, Pei D, Sandlund JT, Jeha S, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff S, Onciu M, Cheng C, Coustan-Smith E, Bowman WP, Howard SC, Metzger ML, Inaba H, Leung W, Evans WE, Campana D, Relling MV, Pui CH. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia 26:265-270, 2012. [Hematological Malignancies]. PMCID: PMC3345278 PUBMEDID: 21869842 NIHMSID: NIHMSID358751. (Journal Impact Factor 2012=10.164)

  • Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, Mullighan CG. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481:157-163, 2012. [Cancer Biology, Hematological Malignancies]. PMCID: PMC3267575 PUBMEDID: 22237106 NIHMSID: NIHMS348037. (Journal Impact Factor 2012=38.597)

  • Inaba H, Hartford CM, Pei D, Posner MJ, Yang J, Hayden RT, Srinivasan A, Triplett BM, McCulllers JA, Pui CH, Leung W. Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation. Br J Haematol 156:109-117, 2012. [Hematological Malignancies]. PMCID: PMC3237834 PUBMEDID: 22017512 NIHMSID: NIHMS327339. (Journal Impact Factor 2012=4.942)

  • Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng C, Pei D, Hankins G, Pauley JL, Pui CH. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57:1147-1153, 2011. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3136575 PUBMEDID: 21319291 NIHMSID: NIHMS262316. (Journal Impact Factor 2011=1.891)

  • Diouf B, Cheng Q, Krynetskaia NF, Yang W, Cheok M, Pei D, Fan Y, Cheng C, Krynetskiy EY, Geng H, Chen S, Thierfelder WE, Mullighan CG, Downing JR, Hsieh P, Pui CH, Relling MV, Evans WE. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nat Med 17:1298-1303, 2011. [Molecular Oncology, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3192247 PUBMEDID: 21946537 NIHMSID: NIHMS309529. (Journal Impact Factor 2011=22.462)

  • Brennan RC, Helton KJ, Pei D, Cheng C, Inaba H, Metzger ML, Howard SC, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Pui CH, Bhojwani D. Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol 90:1067-1074, 2011. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC3169011 PUBMEDID: 21340722 NIHMSID: NIHMS317714. (Journal Impact Factor 2011=2.615)

  • Pillai A, Hartford C, Wang C, Pei D, Yang J, Srinivasan A, Triplett B, Dallas M, Leung W. Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia. Pediatr Transplant 15:628-634, 2011. [Signal Transduction, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3538876 PUBMEDID: 21762328 NIHMSID: NIHMS319416. (Journal Impact Factor 2011=1.475)

  • Inaba H, Bhojwani D, Pauley JL, Pei D, Cheng C, Metzger ML, Howard SC, Rubnitz JE, Sandlund JT, Ribeiro RC, Leung W, Campana D, Pui CH, Jeha S. Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol 156:275-279, 2011. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3235268 PUBMEDID: 21883141 NIHMSID: NIHMSID316135. (Journal Impact Factor 2011=4.941)

  • Leung W, Campana D, Yang J, Pei D, Coustan-Smith E, Gan K, Rubnitz JE, Sandlund JT, Ribeiro RC, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Handgretinger R, Laver JH, Pui CH. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 118:223-230, 2011. [Signal Transduction, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3138677 PUBMEDID: 21613256 NIHMSID: . (Journal Impact Factor 2011=9.898)

  • Assumpcao JG, Seidinger AL, Mastellato MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC, Dufloth RM, Brandalise SR, Yunes JA. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil (vol 8, Art. 357, 2008) CORRECTION. BMC Cancer 11:152-, 2011. [Cancer Biology, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: Correction PUBMEDID: Not indexed in PubMed NIHMSID: . (Journal Impact Factor 2011=3.011)

  • Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 117:2340-2347, 2011. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3062406 PUBMEDID: 21148812 NIHMSID: . (Journal Impact Factor 2011=9.898)

  • Nguyen P, Ma J, Pei D, Obert C, Cheng C, Geiger TL. Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire. BMC Genomics 12:1-13, 2011. [Signal Transduction, Hematological Malignancies]. PMCID: PMC3045962 PUBMEDID: 21310087 NIHMSID: . (Journal Impact Factor 2011=4.073)

  • Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Coustan-Smith E, Jeha S, Cheng C, Metzger ML, Bhojwani D, Inaba H, Raimondi SC, Onciu M, Howard SC, Leung W, Downing JR, Evans WE, Relling MV. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 29:386-391, 2011. [Molecular Oncology, Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3058285 PUBMEDID: 21172890 NIHMSID: . (Journal Impact Factor 2011=18.372)

  • Pottier N, Paugh SW, Ding C, Pei D, Yang W, Das S, Cook EH, Pui CH, Relling MV, Cheok MH, Evans WE. Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia. . Clin Pharmacol Ther 88:854-861, 2010. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3105596 PUBMEDID: 20981007 NIHMSID: NIHMSID292245. (Journal Impact Factor 2010=6.378)

  • Ashford J, Schoffstall C, Reddick WE, Leone C, Laningham FH, Glass JO, Pei D, Cheng C, Pui CH, Conklin HM. Attention and working memory abilities in children treated for acute lymphoblastic leukemia. Cancer 116:4638-4645, 2010. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC2946517 PUBMEDID: 20572038 NIHMSID: NIHMS212777. (Journal Impact Factor 2010=5.131)

  • Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, Evans WE, Pui CH, Relling MV. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther 88:191-196, 2010. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC3000799 PUBMEDID: 20592726 NIHMSID: NIHMSID252173. (Journal Impact Factor 2010=6.378)

  • Trevino LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM, Pui CH, Evans WE, Relling MV. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol 27:5972-5978, 2009. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2793040 PUBMEDID: 19901119 NIHMSID: . (Journal Impact Factor 2009=17.793)

  • Jeha S, Pei D, Raimondi SC, Onciu M, Campana D, Cheng C, Sandlund JT, Ribeiro RC, Rubnitz JE, Howard SC, Downing JR, Evans WE, Relling MV, Pui CH. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia 23:1406-1409, 2009. [Molecular Oncology, Developmental Biology and Solid Tumor Program, Signal Transduction, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2731684 PUBMEDID: 19282835 NIHMSID: NIHMS110407. (Journal Impact Factor 2009=8.296)

  • Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC2754320 PUBMEDID: 19553647 NIHMSID: NIHMS118392. (Journal Impact Factor 2009=47.05)

  • Childhood Acute Lymphoblastic Leukaemia Collaborative Group, Yetgin S, Ozbek NY, Masera G, Valsecchi MG, Dacou V, Loening L, Schrappe M, Zimmermann M, Henze G, von Stackelberg A, Gadner H, Mann G, Attarbaschi A, Brandalise SR, Carroll WL, Gaynon P, Boyett JM, Nachman J, Devidas M, Sather HN, Escherich G, Janka G, Gelber RD, Sallan SE, Pieters R, Bierings M, Kamps WA, Otten J, Suciu S, Viana MB, Baruchel A, Auclerc M, Perez C, Solidaro A, Stark B, Steinberg D, Koizumi S, Tsurusawa M, Zintl F, Schiller I, Matsuzaki A, Eden TOB, Lilleyman JS, Richards S, Steinherz PG, Steinherz L, Kochupillai V, Bakhshi S, Ortega JJ, Nachman J, Appelbaum FR, Cheng C, Pei D, Pui CH, Kukure P, Nakazawa S, Tsuchida M, Elphinstone T, Evans V, Gettins L, Hicks C, MacKinnon L, Morris P, Richards S, Wade R. Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis. Br J Haematol 145:376-388, 2009. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC2812732 PUBMEDID: 19236609 NIHMSID: NIHMS163765. (Journal Impact Factor 2009=N/A)

  • Stocco G, Cheok MH, Crews KR, Dervieux T, French D, Pei D, Yang W, Cheng C, Pui CH, Relling M, Evans W. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther 85:164-172, 2009. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2762405 PUBMEDID: 18685564 NIHMSID: NIHMSID68384. (Journal Impact Factor 2009=6.961)

  • Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, Biondi A, Pui CH, Downing JR, Campana D. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 10:147-156, 2009. [Molecular Oncology, Signal Transduction, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2840241 PUBMEDID: 19147408 NIHMSID: NIHMSID118479. (Journal Impact Factor 2009=14.47)

  • Yang JJ, Cheng C, Yang W, Pei D, Cao X, Fan Y, Pounds SB, Neale G, Trevino LR, French D, Campana D, Downing JR, Evans WE, Pui CH, Devidas M, Bowman WP, Camitta BM, Willman CL, Davies SM, Borowitz MJ, Carroll WL, Hunger SP, Relling MV. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 301:393-403, 2009. [Molecular Oncology, Signal Transduction, Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PMC2664534 PUBMEDID: 19176441 NIHMSID: NIHMSID89586. (Journal Impact Factor 2009=28.899)

  • Pottier N, Yang W, Assem M, Panetta JC, Pei D, Paugh SW, Cheng C, Den Boer ML, Relling MV, Pieters R, Evans WE, Cheok MH. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst 100:1792-1803, 2008. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2639326 PUBMEDID: 19066270 NIHMSID: . (Journal Impact Factor 2008=N/A)

  • Yang J, Bogni A, Cheng C, Bleibel WK, Cai X, Fan Y, Yang W, Rocha JCC, Pei D, Liu W, Dolan ME, Pui CH, Relling MV. Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clin Pharmacol Ther 84:691-697, 2008. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2583166 PUBMEDID: 18509329 NIHMSID: NIHMSID68319. (Journal Impact Factor 2008=7.586)

  • Assumpcao JG, Seidinger AL, Mastellaro MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC, Dufloth RM, Brandalise SR, Yunes JA. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8:1-6, 2008. [Molecular Oncology, Signal Transduction, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2631588 PUBMEDID: 19046423 NIHMSID: . (Journal Impact Factor 2008=N/A)

  • Yang L, Panetta JC, Cai X, Yang W, Pei D, Cheng C, Kornegay N, Pui CH, Relling MV. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol 26:1932-1939, 2008. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PUBMEDID: 18421047 NIHMSID: . (Journal Impact Factor 2008=17.157)

  • Sorich MJ, Pottier N, Pei D, Yang W, Kager L, Stocco G, Cheng C, Panetta JC, Pui CH, Relling MV, Cheok MH, Evans WE. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS Med 5:0646-0656, 2008. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC2292747 PUBMEDID: 18416598 NIHMSID: . (Journal Impact Factor 2008=12.185)

  • Hargrove PW, Kepes S, Hanawa H, Obenauer JC, Pei D, Cheng C, Gray JT, Neale G, Persons DA. Globin lentiviral vector insertions can perturb the expression of endogenous genes in b-thalassemic hematopoietic cells. Mol Ther 16:525-533, 2008. [Signal Transduction, Hematological Malignancies]. PMCID: PUBMEDID: 18195719 NIHMSID: . (Journal Impact Factor 2008=5.97)

  • Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, Downing JR, Campana D. Response: Genes associated with response to therapy in childhood acute lymphoblastic leukemia. Blood 111:2487-2488, 2008. [Hematological Malignancies]. PMCID: Correspondence PUBMEDID: Not indexed in PubMed NIHMSID: . (Journal Impact Factor 2008=10.432)

  • Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, Downing JR, Campana D. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 110:1271-1277, 2007. [Hematological Malignancies]. PMCID: PMC1939904 PUBMEDID: 17456722 NIHMSID: . (Journal Impact Factor 2007=10.896)

  • Thornton JD, Swanson DJ, Mary MN, Pei D, Martin AC, Pounds S, Goldowitz D, Skapek SX. Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the Arf tumor suppressor. Invest Ophthalmol Vis Sci 48:491-499, 2007. [Molecular Oncology]. PMCID: PUBMEDID: 17251441 NIHMSID: . (Journal Impact Factor 2007=N/A)

  • Kishi S, Cheng C, French D, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner GL, Frudakis T, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 109:4151-4157, 2007. [Hematological Malignancies]. PMCID: PMC1885506 PUBMEDID: 17264302 NIHMSID: . (Journal Impact Factor 2007=10.896)

  • Jeha S, Behm F, Pei D, Sandlund JT, Ribeiro RC, Razzouk BI, Rubnitz JE, Hijiya N, Howard SC, Cheng C, Pui CH. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia. Blood 108:3302-3304, 2006. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC1895438 PUBMEDID: 16896151 NIHMSID: . (Journal Impact Factor 2006=10.37)

  • Holleman A, den Boer ML, Cheok MH, Kazemier KM, Pei DQ, Downing JR, Janka-Schaub GE, Gobel U, Graubner UB, Pui CH, Evans WE, Pieters R. Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols. Blood 108:1984-1990, 2006. [Hematological Malignancies]. PMCID: PMC1895531 PUBMEDID: 16709928 NIHMSID: . (Journal Impact Factor 2006=10.37)

  • Flotho C, Coustan-Smith E, Pei D, Iwamoto S, Song G, Cheng C, Pui CH, Downing JR, Campana D. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood 108:1050-1057, 2006. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PMC1895863 PUBMEDID: 16627760 NIHMSID: . (Journal Impact Factor 2006=10.37)

  • Pui CH, Pei D, Sandlund JT, Campana D, Ribeiro RC, Razzouk BI, Rubnitz JE, Howard SC, Hijiya N, Jeha S, Cheng C, Downing JR, Evans WE, Relling MV, Hudson M. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:7936-7941, 2005. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PUBMEDID: 16258093 NIHMSID: . (Journal Impact Factor 2005=11.81)

  • Edick MJ, Cheng C, Yang W, Cheok M, Wilkinson MR, Pei D, Evans WE, Kun LE, Pui CH, Relling MV. Lymphoid gene expression as a predictor of risk of secondary brain tumors. Genes Chromosomes Cancer 42:107-116, 2005. [Developmental Biology and Solid Tumor Program, Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PUBMEDID: 15543619 NIHMSID: . (Journal Impact Factor 2005=N/A)

  • Cheng C, Pounds SB, Boyett JM, Pei D, Kuo M-L, Roussel MF. Statistical significance threshold criteria for analysis of microarray gene expression data. Stat Appl Genet Mol Biol 3:Article 36-, 2004. [Cancer Biology, Hematological Malignancies, Neurobiology & Brain Tumor]. PMCID: PUBMEDID: 16646816 NIHMSID: . (Journal Impact Factor 2004=N/A)

  • Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson MM, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children's Research Hospital. Blood 104:2690-2696, 2004. [Hematological Malignancies, Cancer Control and Survivorship, Neurobiology & Brain Tumor]. PMCID: PUBMEDID: 15251979 NIHMSID: . (Journal Impact Factor 2004=9.782)

  • Holleman A, Cheok MH, den Boer ML, Yang WJ, Veerman AJP, Kazemier KM, Pei DQ, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351:533-542, 2004. [Hematological Malignancies]. PMCID: PUBMEDID: 15295046 NIHMSID: . (Journal Impact Factor 2004=38.57)

  • Hak LJ, Relling MV, Cheng C, Pei D, Wang B, Sandlund JT, Rubnitz J, Pui CH. Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia. Leukemia 18:1072-1077, 2004. [Hematological Malignancies]. PMCID: PUBMEDID: 15057247 NIHMSID: . (Journal Impact Factor 2004=5.81)

  • Pui CH, Sandlund JT, Pei DQ, Rivera GK, Howard SC, Ribeiro RC, Rubnitz JE, Razzouk BI, Hudson MM, Cheng C, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 290:2001-2007, 2003. [Hematological Malignancies, Cancer Control and Survivorship]. PMCID: PUBMEDID: 14559953 NIHMSID: . (Journal Impact Factor 2003=21.455)

  • Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21:3084-3091, 2003. [Hematological Malignancies]. PMCID: PUBMEDID: 12915598 NIHMSID: . (Journal Impact Factor 2003=10.864)

  • Sawyer MB, Innocenti F, Das S, Cheng C, Ramirez J, Pantle-Fisher FH, Wright C, Badner J, Pei DQ, Boyett JM, Cook E, Ratain MJ. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 73:566-574, 2003. [Hematological Malignancies, Neurobiology & Brain Tumor]. PMCID: PUBMEDID: 12811366 NIHMSID: . (Journal Impact Factor 2003=6.141)

  • Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res 63:1046-1053, 2003. [Molecular Oncology, Signal Transduction, Hematological Malignancies, Neurobiology & Brain Tumor]. PMCID: PUBMEDID: 12615721 NIHMSID: . (Journal Impact Factor 2003=8.649)